These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9552458)

  • 21. Mixing of pharmaceutical powders in tablet manufacture.
    Eyjolfsson R
    Pharmazie; 2001 Jul; 56(7):590-1. PubMed ID: 11487984
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: A torque arm mixer for studying wet massing.
    Travers DN; Rogerson AG; Jones TM
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():3P. PubMed ID: 2703
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of surface roughness and chrome plating of punch tips on the sticking tendencies of model ibuprofen formulations.
    Roberts M; Ford JL; MacLeod GS; Fell JT; Smith GW; Rowe PH
    J Pharm Pharmacol; 2003 Sep; 55(9):1223-8. PubMed ID: 14604465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
    Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
    Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
    Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
    Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
    Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties.
    Herting MG; Kleinebudde P
    Int J Pharm; 2007 Jun; 338(1-2):110-8. PubMed ID: 17324537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
    Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of indomethacin, naproxen, and ibuprofen in pharmaceutical dosage forms by first and second derivative ultraviolet spectrometry.
    Mahrous MS; Abdel-Khalek MM; Abdel-Hamid ME
    J Assoc Off Anal Chem; 1985; 68(3):535-9. PubMed ID: 4019382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of beam size on real-time determination of powder blend homogeneity by an online near infrared sensor.
    Li W; Johnson MC; Bruce R; Rasmussen H; Worosila GD
    J Pharm Biomed Anal; 2007 Jan; 43(2):711-7. PubMed ID: 16908115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental research on drug evaluation of ibuprofen oral drop].
    Zhan DZ; Zhu ZG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):233-4. PubMed ID: 12575300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Nov; 17(9):450-61. PubMed ID: 4888356
    [No Abstract]   [Full Text] [Related]  

  • 34. Fast dispersible/slow releasing ibuprofen tablets.
    Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
    Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements.
    Moes JJ; Ruijken MM; Gout E; Frijlink HW; Ugwoke MI
    Int J Pharm; 2008 Jun; 357(1-2):108-18. PubMed ID: 18394831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peroral long-acting drugs. VII. Tablets prepared of a granulated powder coated with fatty acids].
    Chalabala M; Starha L; Muzik M
    Cesk Farm; 1972 May; 21(4):153-5. PubMed ID: 5046010
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the morphogranulometry and hydrophobicity of talc on its antisticking power in the production of tablets.
    Leterme P; Gayot A; Finet G; Bizi M; Flament MP
    Int J Pharm; 2005 Jan; 289(1-2):109-15. PubMed ID: 15652204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on direct compression of tablets. I. The effect of particle size in mixing finely divided powders with granules.
    Nyström C; Malmqvist K
    Acta Pharm Suec; 1980; 17(5):282-7. PubMed ID: 7223443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.